Literature DB >> 11094215

Severe oligohydramnios induced by cyclooxygenase-2 inhibitor nimesulide.

R P Holmes1, P R Stone.   

Abstract

BACKGROUND: Cyclooxygenase-2 inhibitors might have fewer adverse fetal effects than conventional nonsteroidal anti-inflammatory drugs that inhibit both isoforms of the enzyme. Although cyclooxygenase-2 is expressed in fetal kidneys, there are no reports of adverse effects in human pregnancy. CASE: A 27-year-old woman, gravida 2, para 0, with a twin pregnancy at 24 weeks' gestation had placement of a cervical cerclage. Nimesulide was prescribed for postoperative preterm labor prophylaxis. Three weeks later, severe oligohydramnios was identified in both sacs, despite normal growth, renal anatomy, and umbilical artery and renal artery Doppler flow velocimetry. After stopping the drug, amniotic fluid volumes returned to normal over 2 weeks. There were no adverse neonatal renal effects.
CONCLUSION: Selective cyclooxygenase-2 inhibition might cause severe oligohydramnios. If it is used, we advise close fetal surveillance.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11094215     DOI: 10.1016/s0029-7844(00)01047-4

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  8 in total

1.  Potential risk factors for the development of acute renal failure in preterm newborn infants: a case-control study.

Authors:  L Cataldi; R Leone; U Moretti; B De Mitri; V Fanos; L Ruggeri; G Sabatino; F Torcasio; V Zanardo; G Attardo; F Riccobene; C Martano; D Benini; L Cuzzolin
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-11       Impact factor: 5.747

2.  Postnatal renal function in preterm newborns: a role of diseases, drugs and therapeutic interventions.

Authors:  Laura Cuzzolin; Vassilios Fanos; Bernadette Pinna; Maria di Marzio; Monica Perin; Paola Tramontozzi; Paola Tonetto; Luigi Cataldi
Journal:  Pediatr Nephrol       Date:  2006-05-25       Impact factor: 3.714

3.  Renal tubular dysgenesis associated with in utero exposure to Nimuselide.

Authors:  Uma Sankari Ali; Sheila Khubchandani; Parmanand Andankar; Shashank Parekhji; Vishal Dubhalish; Bhavna Padhye
Journal:  Pediatr Nephrol       Date:  2005-12-03       Impact factor: 3.714

Review 4.  Effects of maternally administered drugs on the fetal and neonatal kidney.

Authors:  Farid Boubred; Mariella Vendemmia; Patricia Garcia-Meric; Christophe Buffat; Veronique Millet; Umberto Simeoni
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 5.  Lupus activity in pregnancy.

Authors:  Megan E B Clowse
Journal:  Rheum Dis Clin North Am       Date:  2007-05       Impact factor: 2.670

6.  In utero exposure to nonsteroidal anti-inflammatory drugs: neonatal renal failure.

Authors:  Daniela Benini; Vassilios Fanos; Laura Cuzzolin; Luciano Tatò
Journal:  Pediatr Nephrol       Date:  2003-11-25       Impact factor: 3.714

7.  LncRNA and transcriptomic analysis of fetal membrane reveal potential targets involved in oligohydramnios.

Authors:  Yu-Hua Ou; Yu-Kun Liu; Li-Qiong Zhu; Man-Qi Chen; Xiao-Chun Yi; Hui Chen; Jian-Ping Zhang
Journal:  BMC Med Genomics       Date:  2020-09-18       Impact factor: 3.063

Review 8.  Different Chemical Structures and Physiological/Pathological Roles of Cyclooxygenases.

Authors:  Yalcin Faki; Ayse Er
Journal:  Rambam Maimonides Med J       Date:  2021-01-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.